Literature DB >> 14521168

Clinical application of sodium profiling in the treatment of intradialytic hypotension.

L Colì1, M Ursino, G Donati, G Cianciolo, M L Soverini, O Baraldi, G La Manna, G Feliciangeli, M P Scolari, S Stefoni.   

Abstract

BACKGROUND: Intradialytic hypotension is mainly induced by the removal of extracellular sodium during dialysis, which impairs intravascular fluid refilling and reduces blood volume. To counter this complication we tested a new kind of profiled hemodialysis (PHD) consisting of the intradialytic modulation of dialysate sodium concentration according to individual profiles set up using a new mathematical model for intradialytic solutes and water kinetics. The clinical aim of this PHD is to stabilize blood pressure maintaining higher blood volume values than standard dialysis treatments. We clinically validated PHD in comparison with constant dialysate sodium dialysis (CHD).
METHODS: Twenty hypotensive dialysis patients underwent one PHD and one CHD session maintaining the same dialysis length, sodium mass removal and body weight decrease. A new mathematical model was used to define both the dialysate sodium profiles for PHD and the constant dialysate sodium for CHD. Percent blood volume variation (Crit-line), mean blood pressure, heart rate, cardiac output (Doppler-echocardiography) were monitored intradialitically.
RESULTS: Cardiovascular stability improved on PHD as compared with CHD sessions; blood volume and cardiac output during PHD showed a lower decrease than on CHD, the differences statistically significant (from 30' and 60' respectively). Mean blood pressure was, at all time intervals, more stable on PHD than on CHD and was accompanied, on PHD, by a lower heart rate increase (differences statistically significant).
CONCLUSIONS: This study shows that PHD performed using dialysate sodium profiles elaborated by our mathematical model obtains, in hypotensive patients, a higher hemodynamic intradialytic stability than CHD, probably due to a higher stabilization of blood volume.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14521168     DOI: 10.1177/039139880302600803

Source DB:  PubMed          Journal:  Int J Artif Organs        ISSN: 0391-3988            Impact factor:   1.595


  4 in total

1.  Sodium modelling to reduce intradialytic hypotension during haemodialysis for acute kidney injury in the intensive care unit.

Authors:  Katherine E Lynch; Fatimah Ghassemi; Jennifer E Flythe; Mengling Feng; Marzyeh Ghassemi; Leo Anthony Celi; Steven M Brunelli
Journal:  Nephrology (Carlton)       Date:  2016-10       Impact factor: 2.506

2.  Randomized Crossover Trial of Blood Volume Monitoring-Guided Ultrafiltration Biofeedback to Reduce Intradialytic Hypotensive Episodes with Hemodialysis.

Authors:  Kelvin C W Leung; Robert R Quinn; Pietro Ravani; Henry Duff; Jennifer M MacRae
Journal:  Clin J Am Soc Nephrol       Date:  2017-10-10       Impact factor: 8.237

3.  Seroprevalence of a "new" bacterium, Simkania negevensis, in renal transplant recipients and in hemodialysis patients.

Authors:  Andrea Angeletti; Roberta Biondi; Giuseppe Battaglino; Eleonora Cremonini; Giorgia Comai; Irene Capelli; Gabriele Donati; Roberto Cevenini; Manuela Donati; Gaetano La Manna
Journal:  BMC Nephrol       Date:  2017-04-13       Impact factor: 2.388

4.  Effect of a plasma sodium biofeedback system applied to HFR on the intradialytic cardiovascular stability. Results from a randomized controlled study.

Authors:  Francesco Locatelli; Sergio Stefoni; Thierry Petitclerc; Luigi Colì; Salvatore Di Filippo; Simeone Andrulli; Christine Fumeron; Giovanni Maria Frascà; Sibilla Sagripanti; Silvana Savoldi; Andrea Serra; Carmine Stallone; Filippo Aucella; Antonio Gesuete; Antonio Scarlatella; Francesco Quarello; Paola Mesiano; Peter Ahrenholz; Roland Winkler; Lise Mandart; Joan Fort; Christian Tielemans; Carlo Navino
Journal:  Nephrol Dial Transplant       Date:  2012-05-04       Impact factor: 5.992

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.